Shutting Down Deadly Pediatric Brain Cancer at Its Earliest Moments

Cell-by-cell genetic analyses of developing brain tissues in neonatal mice and laboratory models of brain cancer allowed scientists to discover a molecular driver of the highly aggressive, deadly, and treatment-resistant brain cancer, glioblastoma. ...
8-Apr-2019 6:00 AM EDT Add to Favorites

High-Tech Tissue Study Reveals Which Cells Drive a Painful Food Allergy

New study uses single-cell RNA sequencing technology to find a target for treating EoE. Findings also raise questions about the dietary supplement butyrate.
9-Apr-2019 10:05 AM EDT Add to Favorites

Study Shows How Light Therapy Might Help Premature Babies Avoid Vision Problems

Scientists discovered a light-dependent molecular pathway that regulates how blood vessels develop in the eye. The findings in Nature Cell Biology suggest it may be possible to use light therapy to help premature infants whose eyes are still...
28-Mar-2019 11:00 AM EDT Add to Favorites

Cardiovascular Screenings Uncover Two Cases of Diabetes And Significant Levels of High Cholesterol in Middle Schoolers

A pilot study of 45 middle school kids shows that more than a third of those screened had abnormal levels of blood sugar or high cholesterol. Two had blood sugar levels (HbA1c) in the diabetes range.
12-Mar-2019 11:30 AM EDT Add to Favorites

Scientists Reveal How 3D Arrangement of DNA Helps Perpetuate the Species

From fathers to children, the delivery of hereditary information requires the careful packing of DNA in sperm. But just how nature packages this DNA to prepare offspring isn’t clear. Using new technology to reveal the 3D organization of DNA in...
14-Feb-2019 11:05 AM EST Add to Favorites

Close to Half a Million E-Valentines Sent to Patients at Cincinnati Children’s

Record number makes Valentine’s Day a little sweeter for patients and families
14-Feb-2019 10:30 AM EST Add to Favorites

NIAID-Sponsored Clinical Trial of Ebola Vaccines Begins at Cincinnati Children's

A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) has begun in the United States at Cincinnati Children’s Hospital Medical Center. The study is sponsored by the National Institute of Allergy...
28-Jan-2019 9:05 AM EST Add to Favorites

Early Clinical Trial Data Show Gene Therapy Reversing Sickle Cell Anemia

After over a decade of preclinical research and development, a new gene therapy treatment for Sickle Cell Anemia (SCA) is reversing disease symptoms in two adults and showing early potential for transportability to resource-challenged parts of the...
3-Dec-2018 1:05 PM EST Add to Favorites

see all news